Concepedia

Colette Kosik‐Gonzalez

CK

9

Publications

659

Citations

9

H-Index

2006

Active since

Affiliations

Janssen (United States)(Current)

Johnson & Johnson (United States)

Janssen Scientific Affairs (United States)

OptiNose (United States)

OptiNose (Norway)

Colette Kosik‐Gonzalez is an author at Janssen (United States) specializing in psychopharmacology, schizophrenia, and medicine.

Top concepts

Publications per year

2006–2018

9

Publications

9

Risperidone for Treatment-Refractory Major Depressive Disorder

Ramy Mahmoud, Gahan Pandina, Ibrahim Turkoz et al. · Annals of Internal Medicine · 2007 · 134 citations

NAVIGATE II: Randomized, double-blind trial of the exhalation delivery system with fluticasone for nasal polyposis

Donald A. Leopold, David Elkayam, John Messina et al. · Journal of Allergy and Clinical Immunology · 2018 · 99 citations · Full text

A double-blind comparison of risperidone, quetiapine and placebo in patients with schizophrenia experiencing an acute exacerbation requiring hospitalization

Steven G. Potkin, Georges M. Gharabawi, Andrew Greenspan et al. · Schizophrenia Research · 2006 · 94 citations

, , +7

Randomized, Double-Blind, Placebo-Controlled Study of Paliperidone Extended-Release and Quetiapine in Inpatients With Recently Exacerbated Schizophrenia

Carla M. Canuso, Bryan Dirks, Jennifer Carothers et al. · American Journal of Psychiatry · 2009 · 75 citations

A Randomized, Double-Blind, Placebo-Controlled Study of 2 Dose Ranges of Paliperidone Extended-Release in the Treatment of Subjects With Schizoaffective Disorder

Carla M. Canuso, Jean‐Pierre Lindenmayer, Colette Kosik‐Gonzalez et al. · The Journal of Clinical Psychiatry · 2010 · 63 citations

Rows per page

1–5 of 9